Skip to content

Laboratoire Colman: what changed

What changed

Laboratoire Colman

BE 0401.753.610
NACE 46.460, Wholesale of pharmaceutical and medical goods
filed annual accounts (NBB)
Financial years compared with
Net result for the year
-€12,676
2022 · -€15,407+€2,731
Equity
€8,320
2022 · €20,996-€12,676
Cash
€4,618
2022 · €25,550-€20,932
Balance sheet total
€42,585
2022 · €43,405-€821

Largest movements

2022 to 2023
Assets
  • Receivables within one year +€22,911

    up €22,911 (+1,173%), from €1,953 to €24,864

    of which Trade receivables: +€23,766

  • Cash -€20,932

    down €20,932 (-81.9%), from €25,550 to €4,618

    mainly Receivables within one year (-€22,911) and Net result for the year (-€12,676)

  • Deferred charges and accrued income -€2,800

    no longer reported in 2023 (was €2,800)

Equity and liabilities
  • Profit (loss) carried forward -€12,676

    down €12,676 (-30.0%), from -€42,254 to -€54,930

  • Trade debts +€10,075

    up €10,075 (+115%), from €8,732 to €18,807

  • Other debts +€9,158

    up €9,158 (+145%), from €6,300 to €15,457

  • Tax, wage and social debts -€7,378

    no longer reported in 2023 (was €7,378)

Income statement
  • Gross operating margin -€24,112

    down €24,112, from €23,545 to -€567

  • Staff costs -€20,540

    down €20,540 (-63.4%), from €32,408 to €11,867

  • Write-downs -€4,064

    no longer reported in 2023 (was €4,064)

  • Other operating charges -€348

    down €348 (-93.3%), from €373 to €25

Change in the result, 2022 to 2023

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2022 -€15,407
Gross operating margin -€24,112
Staff costs +€20,540
Write-downs +€4,064
Other operating charges +€348
Other operating items +€2,012
Financial income +€1
Financial charges -€122
Result 2023 -€12,676
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2022 to 2023

The bridge is derived from the 2022 and 2023 balance sheets and the 2023 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations -€20,932
Investment €0
Financing €0
Cash 2022 €25,550
Net result for the year -€12,676
Receivables within one year -€22,911
Deferred charges and accrued income +€2,800
Trade debts +€10,075
Tax, wage and social debts -€7,378
Other debts +€9,158
Cash 2023 €4,618
brings cash intakes cash out
Every line side by side 35 lines
Line Code 2022 2023 Change %
Total assets 20/58 €43,405 €42,585 -€821 -1.9%
Current assets 29/58 €43,405 €42,585 -€821 -1.9%
Stocks and contracts in progress 3 €13,102 €13,102 = 0.0%
Stocks 30/36 €13,102 €13,102 = 0.0%
Amounts receivable within one year 40/41 €1,953 €24,864 +€22,911 +1,173%
Trade receivables 40 €894 €24,660 +€23,766 +2,658%
Other amounts receivable 41 €1,059 €204 -€855 -80.7%
Cash at bank and in hand 54/58 €25,550 €4,618 -€20,932 -81.9%
Deferred charges and accrued income 490/1 €2,800 - -€2,800
Total equity and liabilities 10/49 €43,405 €42,585 -€821 -1.9%
Equity 10/15 €20,996 €8,320 -€12,676 -60.4%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €44,650 €44,650 = 0.0%
Distributable reserves 133 €44,650 €44,650 = 0.0%
Profit (loss) carried forward 14 -€42,254 -€54,930 -€12,676 -30.0%
Amounts payable 17/49 €22,409 €34,264 +€11,855 +52.9%
Amounts payable within one year 42/48 €22,409 €34,264 +€11,855 +52.9%
Trade debts 44 €8,732 €18,807 +€10,075 +115%
Suppliers 440/4 €8,732 €18,807 +€10,075 +115%
Taxes, remuneration and social security 45 €7,378 - -€7,378
Remuneration and social security 454/9 €7,378 - -€7,378
Other amounts payable 47/48 €6,300 €15,457 +€9,158 +145%
Remuneration, social security and pensions 62 €32,408 €11,867 -€20,540 -63.4%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 €4,064 - -€4,064
Other operating charges 640/8 €373 €25 -€348 -93.3%
Non-recurring operating charges 66A €2,012 - -€2,012
Gross operating margin 9900 €23,545 -€567 -€24,112
Operating profit (loss) 9901 -€15,311 -€12,459 +€2,852 +18.6%
Financial income 75/76B €0 €1 +€1 +10,000%
Recurring financial income 75 €0 €1 +€1 +10,000%
Financial charges 65/66B €96 €217 +€122 +127%
Recurring financial charges 65 €96 €217 +€122 +127%
Profit (loss) for the period before taxes 9903 -€15,407 -€12,676 +€2,731 +17.7%
Profit (loss) for the period 9904 -€15,407 -€12,676 +€2,731 +17.7%
Profit (loss) for the period to be appropriated 9905 -€15,407 -€12,676 +€2,731 +17.7%
Calculation and sources

Source: filed annual accounts (NBB), financial years ended 31 December 2022 and 31 December 2023. Green is a favourable move for that line, red an unfavourable one. Prepared on 7 November 2026 via checked.be.